ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.00
1.33%
US Tech 100
18,982.40
-1.17%
S&P 500
5,447.87
-0.31%
US Dollar vs CAD
1.36535
-0.03%
Bitcoin
61,124.06
1.43%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GeoVax Labs Inc (GOVXW)

  7. GeoVax Labs Inc (GOVXW) News

GOVXW

GeoVax Labs (GOVXW)

GeoVax Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GOVXW
DateTimeSourceHeadlineSymbolCompany
06/19/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXWGeoVax Labs Inc
06/18/202412:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
06/07/20243:01PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GOVXWGeoVax Labs Inc
05/24/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
05/23/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
05/21/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
05/21/202411:32AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GOVXWGeoVax Labs Inc
05/15/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXWGeoVax Labs Inc
05/14/20244:09PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
05/14/20244:09PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
05/14/20244:08PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
05/14/20244:07PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXWGeoVax Labs Inc
05/14/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOVXWGeoVax Labs Inc
04/04/202411:30AMGlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXWGeoVax Labs Inc
03/28/20248:00AMGlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXWGeoVax Labs Inc
03/12/20248:00AMGlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXWGeoVax Labs Inc
03/06/20248:00AMGlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXWGeoVax Labs Inc
02/29/20243:00PMGlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXWGeoVax Labs Inc
02/22/20248:00AMGlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXWGeoVax Labs Inc
02/19/20248:00AMGlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXWGeoVax Labs Inc
02/13/20248:00AMGlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXWGeoVax Labs Inc
02/06/20248:00AMGlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXWGeoVax Labs Inc
01/29/20248:00AMGlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXWGeoVax Labs Inc
01/08/20248:00AMGlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXWGeoVax Labs Inc
01/04/20248:00AMGlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXWGeoVax Labs Inc
01/03/20248:00AMGlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXWGeoVax Labs Inc
12/27/20238:00AMGlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXWGeoVax Labs Inc
12/19/20238:00AMGlobeNewswire Inc.GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and SmallpoxNASDAQ:GOVXWGeoVax Labs Inc
11/30/20233:30PMGlobeNewswire Inc.GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine CongressNASDAQ:GOVXWGeoVax Labs Inc
11/29/20238:00AMGlobeNewswire Inc.GeoVax to Participate in Upcoming December Investor EventsNASDAQ:GOVXWGeoVax Labs Inc
 Showing the most relevant articles for your search:NASDAQ:GOVXW

Your Recent History

LSE
BP24
Motability 54
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved